Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UT-15C SR Long-term Extension in Pulmonary Arterial Hypertension
CTR20130208Phase 3Active
- Sponsor
- United Pharmaceutical Company
- Start
- Nov 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of treprostinil in pulmonary arterial hypertension (PAH), sponsored by United Pharmaceutical Company. Started Nov 2013; status: active.
02
Drugs
treprostinil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on CTR20130208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130208.